Literature DB >> 17970029

Roles of insulin-like growth factor binding protein-2 (IGFBP-2) in glioblastoma.

Tsuyoshi Fukushima1, Hiroaki Kataoka.   

Abstract

Insulin-like growth factor binding protein-2 (IGFBP-2) is reported to be a modulator of the action of insulin-like growth factors (IGFs), whereas IGF-independent effects of IGFBP-2 on cellular proliferation, apoptosis, and mobility have been revealed not only during the embryonic state but also in the pathological state of cancer. As well as other types of carcinomas, overexpression of IGFBP-2 has been reported in glioblastoma multiforme (GBM), the most malignant brain tumor characterized by rapid growth, extensive invasiveness, and angiogenesis. However, it remains unclear how IGFBP-2 is involved in the malignant features of GBM. This review outlines the IGF-dependent and -independent functions of IGFBP-2 and focuses on the roles of IGFBP-2 in the progression of GBM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17970029

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  23 in total

1.  Insulin like growth factor binding protein 4 promotes GBM progression and regulates key factors involved in EMT and invasion.

Authors:  V R Praveen Kumar; Priyanka Sehgal; Balram Thota; Shilpa Patil; Vani Santosh; Paturu Kondaiah
Journal:  J Neurooncol       Date:  2014-01-07       Impact factor: 4.130

2.  Expression pattern and prognostic significance of IGFBP isoforms in anaplastic astrocytoma.

Authors:  A Kulkarni; B Thota; M R Srividya; K Thennarasu; A Arivazhagan; V Santosh; B A Chandramouli
Journal:  Pathol Oncol Res       Date:  2012-05-01       Impact factor: 3.201

3.  IGFBP-2 - taking the lead in growth, metabolism and cancer.

Authors:  Steven W Yau; Walid J Azar; Matthew A Sabin; George A Werther; Vincenzo C Russo
Journal:  J Cell Commun Signal       Date:  2015-01-25       Impact factor: 5.782

4.  Hepatic gene expression profiling reveals key pathways involved in leptin-mediated weight loss in ob/ob mice.

Authors:  Ashok Sharma; Shoshana M Bartell; Clifton A Baile; Bo Chen; Robert H Podolsky; Richard A McIndoe; Jin-Xiong She
Journal:  PLoS One       Date:  2010-08-16       Impact factor: 3.240

5.  Comparison of mixed and lamellar coculture spatial arrangements for tissue engineering capillary networks in vitro.

Authors:  Erica B Peters; Nicolas Christoforou; Kam W Leong; George A Truskey
Journal:  Tissue Eng Part A       Date:  2012-11-21       Impact factor: 3.845

Review 6.  IGF-binding protein 2 is a candidate target of therapeutic potential in cancer.

Authors:  Xiaofeng Yao; Shanshan Sun; Xuan Zhou; Wenyu Guo; Lun Zhang
Journal:  Tumour Biol       Date:  2015-12-09

7.  Tumor associated seizures in glioblastomas are influenced by survival gene expression in a region-specific manner: a gene expression imaging study.

Authors:  Jong Woo Lee; Andrew D Norden; Keith L Ligon; Alexandra J Golby; Rameen Beroukhim; John Quackenbush; William Wells; Kristen Oelschlager; Derek Maetzold; Patrick Y Wen
Journal:  Epilepsy Res       Date:  2014-03-12       Impact factor: 3.045

8.  IGFBP2 modulates the chemoresistant phenotype in esophageal adenocarcinoma.

Authors:  Amy L Myers; Lin Lin; Derek J Nancarrow; Zhuwen Wang; Daysha Ferrer-Torres; Dafydd G Thomas; Mark B Orringer; Jules Lin; Rishindra M Reddy; David G Beer; Andrew C Chang
Journal:  Oncotarget       Date:  2015-09-22

9.  Brief alcohol exposure alters transcription in astrocytes via the heat shock pathway.

Authors:  Leonardo Pignataro; Florence P Varodayan; Lindsay E Tannenholz; Petr Protiva; Neil L Harrison
Journal:  Brain Behav       Date:  2013-02-06       Impact factor: 2.708

10.  Multi-study integration of brain cancer transcriptomes reveals organ-level molecular signatures.

Authors:  Jaeyun Sung; Pan-Jun Kim; Shuyi Ma; Cory C Funk; Andrew T Magis; Yuliang Wang; Leroy Hood; Donald Geman; Nathan D Price
Journal:  PLoS Comput Biol       Date:  2013-07-25       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.